Privacy Policy
Signals Blog

Contributors

Categories

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Posts by: Stacey


Right Turn: The women’s health gap is also an innovation gap

Author: Stacey Johnson, 09/04/26

Two articles in an August issue of The Globe and Mail caught my attention. The articles were very different – one was in the news section and one was in business – but they converged on a similar theme: women’s health. Women’s health has been under-researched, creating knowledge, data and clinical gaps. Those gaps translate […]

Right Turn: The real science, real benefits and real risks of peptides

Author: Stacey Johnson, 08/07/26

What are peptides and why are they all over traditional and social media? Peptides are chains of molecules called amino acids that link together; they are smaller versions of proteins. Thousands of naturally occurring peptides have been identified in the human body. They perform a wide variety of biological functions, although scientists continue to discover […]

Approval isn’t access: Why reimbursement matters for advanced therapies

Author: Stacey Johnson, 07/23/26

“Regulatory approval does not translate to dollars for a company, nor does it lead to patients being treated. Without reimbursement, all of the efforts of translation and development are lost.” My former colleague, Mark Curtis, wrote these words back when he blogged for Signals and worked as a business development analyst for CCRM.  At the […]

Right Turn: How celebrities are helping advance cell and gene therapies

Author: Stacey Johnson, 07/09/26

Celebrity health stories often dominate headlines, but their impact extends beyond entertainment news. High-profile diagnoses can raise awareness of rare diseases, increase participation in clinical trials, influence health policy, and accelerate investment in emerging treatments such as cell and gene therapies. Actor Sam Neill, well-known for his role in the Jurassic Park franchise, announced in […]

Right Turn: #NEM2026 and the changing look of engineering

Author: Stacey Johnson, 03/30/26

Although it’s wrapping up, March is National Engineering Month in Canada. This is a great time to ask: Who is building the future of engineering in Canada, and who is still waiting for a seat at the table? Increasingly, that future doesn’t just look like roads and buildings. It looks like regenerative medicine, advanced manufacturing […]